Clinical trials
Phase 2/3 COVID-19 trials in Spain
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
25 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2020 | 10 |
| 2021 | 9 |
| 2022 | 4 |
| 2023 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 14 |
| Terminated | 10 |
| Recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pfizer | 3 |
| Hipra Scientific, S.L.U | 2 |
| Merck Sharp & Dohme LLC | 2 |
| Abivax S.A. | 1 |
| AstraZeneca | 1 |
| BioNTech SE | 1 |
| Boehringer Ingelheim | 1 |
| CureVac | 1 |
| Dompé Farmaceutici S.p.A | 1 |
| Gilead Sciences | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| COVID-19 | 25 |
| Coronavirus Infections | 4 |
| Pneumonia | 3 |
| Communicable Diseases, Emerging | 1 |
| Post-Acute COVID-19 Syndrome | 1 |
Trials
Showing 1 to 25 of 25. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.